SmartTRAK Life Sciences News and Analysis Blog in the Orthopedics, Wound, and Neuro Therapies Market Segments
.png)
Advanced, higher priced biologics push the US OrthoBio Market higher Based on Q418/FY18 SmartTRAK Financ...
Q418 US Spine market remains fairly flat, rounding out a stable but unremarkable FY18. SmartTRAK’s Finan...
Pricing pressure and tough comps slow year end growth SmartTRAK reports that pricing pressure and a slow...
Revenues down again, owing to intense competitive pricing pressures Pricing pressure continued to negati...
Typically, Q4 is a rebound quarter for Total Joints, but SmartTRAK reports that the Q418 US market exper...
01With the upcoming orthopedic conference season upon us, we thought it would be interesting to take a l...
.png)
SmartTRAK highlights trends shaping the Extremities Market It’s no surprise orthopedic companies continu...
OrthoXel is an orthopaedic trauma device company focused on evolving fracture fixation through evidence-...
Will you be attending AAOS this year? SmartTRAK will be exhibiting (booth #6847) and we’re hoping to sch...
Stem cell “secretome” is the latest advancement in regenerative medicine. Will it become the heart of ti...
Login